Topic: remote patient monitoring
Spire Health launched an innovative study to develop digital biomarkers to predict COPD exacerbations and hospitalizations.
Good for up to 90 days, Senseonics’ Eversense CGM comes paired with a mobile app that can notify adults with diabetes if their blood sugar levels go too high or dip too low.
One of the splashier medtech moments of 2018 to come out of an FDA 510(k) decision was the agency’s de novo clearance of the latest Apple Watch and its software allowing on-demand electrocardiograms for the mass-market consumer.
The FDA cleared Current Health’s wearable tracker, designed to be taken home from the hospital after acute care to track a patient’s recovery.
TytoCare is pairing up with big-box electronics retailer Best Buy to put its remote medical exam hardware directly into the hands of consumers.
Bardy Diagnostics, developers of a remote cardiac monitoring chest patch, raised $35.5 million to help fund its platform and expand its sales force.
The Fierce 15 company’s Loop wristband can measure heart rate, respiration and pulse oximetry, and is designed for patients with COPD.
Alongside a notice from the FDA, Medtronic disclosed a cybersecurity vulnerability in its defibrillators and resynchronization therapy hardware.
A toilet seat monitoring system aims to spot the signs of heart failure in the privacy of the home, with the goal of lowering hospital readmissions.
Biotronik received FDA approvals for six high-voltage cardiac rhythm management devices for treating and resynchronizing tachycardia and arrhythmias.